BACE-1 inhibitors (Janssen)

N/A

Report date: 2025/01/26 15:01:47
NME

Base Information

Drug NameBACE-1 inhibitors (Janssen)
Drug Alias NameBACE inhibitor (Johnson & Johnson)JNJ-715754
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitorsBeta-secretase 1 inhibitors
TargetsBeta-secretase 1Beta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Pharmaceutica NV
Inactive CompaniesJohnson & Johnson
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A